Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Harmony Biosciences Holdings, Inc. (HRMY) had Debt to Capital Ratio of 0.15 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$239.46M |
|
$50.87M |
|
$59.65M |
|
$179.81M |
|
$173.97M |
|
$65.49M |
|
$2.00M |
|
$67.49M |
|
$67.49M |
|
$50.87M |
|
$50.87M |
|
$50.87M |
|
$50.87M |
|
$65.49M |
|
$71.28M |
|
57.55M |
|
58.72M |
|
$0.88 |
|
$0.87 |
|
| Balance Sheet Financials | |
$838.80M |
|
$1.44M |
|
$369.42M |
|
$1.21B |
|
$223.40M |
|
$148.51M |
|
$149.69M |
|
$373.10M |
|
$835.12M |
|
$739.74M |
|
$835.12M |
|
57.60M |
|
| Cash Flow Statement Financials | |
$222.05M |
|
$-22.02M |
|
$-6.03M |
|
$453.27M |
|
$647.27M |
|
$194.00M |
|
$34.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.75 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.15 |
0.20 |
|
75.09% |
|
27.35% |
|
27.35% |
|
-- |
|
28.18% |
|
21.24% |
|
$221.84M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
8.67 |
|
2.38 |
|
37.83 |
|
6.09% |
|
6.88% |
|
4.21% |
|
5.17% |
|
$14.50 |
|
$3.78 |
|
$3.78 |
|